Effect of anti-osteoporotic agents on the prevention of bone loss in unloaded bone

Siu,Wing  Sum; Ko,Chun  Hay; Hung,Leung  Kim; Lau,Ching  Po; Lau,Clara   Bik San; Fung,Kwok   Pui; Leung,Ping   Chung

doi:10.3892/mmr.2013.1647

Effect of anti-osteoporotic agents on the prevention of bone loss in unloaded bone

Authors:
- Wing Sum Siu
- Chun Hay Ko
- Leung Kim Hung
- Ching Po Lau
- Clara Bik San Lau
- Kwok Pui Fung
- Ping Chung Leung
View Affiliations

Affiliations: Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, P.R. China, Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, P.R. China
Published online on: August 20, 2013 https://doi.org/10.3892/mmr.2013.1647
Pages: 1188-1194

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pharmaceutical countermeasures to treat disuse osteoporosis are rarely studied. Pharmaceutical studies for the treatment and prevention of osteoporosis depend on the ovariectomized rat model, which is a suitable model for the disease in women. Disuse osteoporosis affects men and women, but there is lack of awareness and relevant pharmaceutical studies for this condition. The objectives of this study were to verify the validity of an unusual tail-suspension rat model in the induction of disuse osteoporosis and subsequent pharmaceutical treatments. This model was created by unloading the hind limbs of the rats in order to create a state of weightlessness in their hindlimb bones. Validation of the model was performed with non-suspended rats. This study included five groups of suspended rats fed with different agents, such as distilled water (control), high-, medium- and low-dose raloxifene and a bisphosphonate (alendronate). The experiment lasted for 28 days. Comparisons were made between the suspended control and treatment groups. Ovariectomized and sham‑operated rats were also included as a reference for bone changes during osteoporosis. Changes in bone mineral density (BMD) at the distal femur and proximal tibia, microarchitecture at the distal femur and biomechanical strength at the diaphyseal femur were studied. Reduction of BMD and deterioration of trabeculae were similar between the suspended control and ovariectomized rats. Loss of BMD induced by tail suspension was reduced most effectively by medium-dose raloxifene. Deterioration of trabecular microarchitecture was also prevented by raloxifene. The tail-suspension rat model is suitable for the study of disuse osteoporosis under the effects of various therapeutic agents. The preventive effects of raloxifene against bone loss under disuse conditions have been demonstrated using this model.

View Figures

View References

1	Takata S and Yasui N: Disuse osteoporosis. J Med Invest. 48:147–156. 2001.
2	Karlsson MK, Nordqvist A and Karlsson C: Physical activity increases bone mass during growth. Food Nutr Res. 52:2008. View Article : Google Scholar
3	Wilsgaard T, Emaus N, Ahmed LA, Grimnes G, Joakimsen RM, Omsland TK and Berntsen GR: Lifestyle impact on lifetime bone loss in women and men: the Tromso Study. Am J Epidemiol. 169:877–886. 2009. View Article : Google Scholar : PubMed/NCBI
4	Ehrlich PJ and Lanyon LE: Mechanical strain and bone cell function: a review. Osteoporos Int. 13:688–700. 2002. View Article : Google Scholar : PubMed/NCBI
5	Bikle DD, Sakata T and Halloran BP: The impact of skeletal unloading on bone formation. Gravit Space Biol Bull. 6:45–54. 2003.
6	Tilton FE, Degioanni JJ and Schneider VS: Long-term follow-up of Skylab bone demineralization. Aviat Space Environ Med. 51:1209–1213. 1980.PubMed/NCBI
7	Smith SM, Wastney ME, O’Brien KO, Morukov BV, Larina IM, Abrams SA, Davis-Street JE, Oganov V and Shackelford LC: Bone markers, calcium metabolism, and calcium kinetics during extended-duration space flight on the mir space station. J Bone Miner Res. 20:208–218. 2005. View Article : Google Scholar
8	Vico L, Collet P, Guignandon A, Lafage-Proust MH, Thomas T, Rehaillia M and Alexandre C: Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet. 355:1607–1611. 2000. View Article : Google Scholar : PubMed/NCBI
9	Sibonga JD, Evans HJ, Sung HG, Spector ER, Lang TF, Oganov VS, Bakulin AV, Shackelford LC and LeBlanc AD: Recovery of spaceflight-induced bone loss: bone mineral density after long-duration missions as fitted with an exponential function. Bone. 41:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
10	Michaëlsson K, Bergström R, Mallmin H, Holmberg L, Wolk A and Ljunghall S: Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int. 6:120–126. 1996.PubMed/NCBI
11	Nayak S, Roberts MS and Greenspan SL: Factors associated with diagnosis and treatment of osteoporosis in older adults. Osteoporos Int. 20:1963–1967. 2009. View Article : Google Scholar : PubMed/NCBI
12	Nelson RE, Nebeker JR, Sauer BC and LaFleur J: Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture. Bone. 50:983–988. 2012. View Article : Google Scholar : PubMed/NCBI
13	Morey-Holton ER and Globus RK: Hindlimb unloading of growing rats: a model for predicting skeletal changes during space flight. Bone. 22:S83–S88. 1998. View Article : Google Scholar : PubMed/NCBI
14	Bloomfield SA, Allen MR, Hogan HA and Delp MD: Site- and compartment-specific changes in bone with hindlimb unloading in mature adult rats. Bone. 31:149–157. 2002. View Article : Google Scholar : PubMed/NCBI
15	Shimano MM and Volpon JB: Biomechanics and structural adaptations of the rat femur after hindlimb suspension and treadmill running. Braz J Med Biol Res. 42:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
16	Saxon LK, Robling AG, Castillo AB, Mohan S and Turner CH: The skeletal responsiveness to mechanical loading is enhanced in mice with a null mutation in estrogen receptor-beta. Am J Physiol Endocrinol Metab. 293:E484–E491. 2007. View Article : Google Scholar : PubMed/NCBI
17	Lanyon LE: Using functional loading to influence bone mass and architecture: objectives, mechanisms, and relationship with estrogen of the mechanically adaptive process in bone. Bone. 18:37S–43S. 1996. View Article : Google Scholar
18	Ehrlich PJ, Noble BS, Jessop HL, Stevens HY, Mosley JR and Lanyon LE: The effect of in vivo mechanical loading on estrogen receptor alpha expression in rat ulnar osteocytes. J Bone Miner Res. 17:1646–1655. 2002. View Article : Google Scholar : PubMed/NCBI
19	Licata AA, Ciaccia AV, Wong M and Draper MW: Raloxifene: a new choice for treating and preventing osteoporosis. Cleve Clin J Med. 67:273–280. 2000. View Article : Google Scholar : PubMed/NCBI
20	Morii H, Ohashi Y, Taketani Y, Fukunaga M, Nakamura T, Itabashi A, Sarkar S and Harper K: Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial. Osteoporos Int. 14:793–800. 2003. View Article : Google Scholar
21	Morey-Holton ER and Globus RK: Hindlimb unloading rodent model: technical aspects. J Appl Physiol. 92:1367–1377. 2002. View Article : Google Scholar : PubMed/NCBI
22	Laib A, Barou O, Vico L, Lafage-Proust MH, Alexandre C and Rügsegger P: 3D micro-computed tomography of trabecular and cortical bone architecture with application to a rat model of immobilisation osteoporosis. Med Biol Eng Comput. 38:326–332. 2000. View Article : Google Scholar : PubMed/NCBI
23	Fitts JM, Klein RM and Powers CA: Comparison of tamoxifen and testosterone propionate in male rats: differential prevention of orchidectomy effects on sex organs, bone mass, growth, and the growth hormone-IGF-I axis. J Androl. 25:523–534. 2004.PubMed/NCBI
24	Urasopon N, Hamada Y, Asaoka K, Cherdshewasart W and Malaivijitnond S: Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas. 56:322–331. 2007. View Article : Google Scholar : PubMed/NCBI
25	Barou O, Lafage-Proust MH, Martel C, Thomas T, Tirode F, Laroche N, Barbier A, Alexandre C and Vico L: Bisphosphonate effects in rat unloaded hindlimb bone loss model: three-dimensional microcomputed tomographic, histomorphometric, and densitometric analyses. J Pharmacol Exp Ther. 291:321–328. 1999.
26	Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F and Lorich DG: Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 22:346–350. 2008. View Article : Google Scholar : PubMed/NCBI
27	Abrahamsen B, Eiken P and Eastell R: Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: A register-based national cohort study. J Bone Miner Res. 24:1095–1102. 2009. View Article : Google Scholar : PubMed/NCBI
28	Migliorati CA, Siegel MA and Elting LS: Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol. 7:508–514. 2006. View Article : Google Scholar : PubMed/NCBI
29	Vieillard MH, Maes JM, Penel G, Facon T, Magro L, Bonneterre J and Cortet B: Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy. Joint Bone Spine. 75:34–40. 2008. View Article : Google Scholar : PubMed/NCBI
30	Li CY, Price C, Delisser K, Nasser P, Laudier D, Clement M, Jepsen KJ and Schaffler MB: Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis. J Bone Miner Res. 20:117–124. 2005. View Article : Google Scholar : PubMed/NCBI
31	Heringa M: Review on raloxifene: profile of a selective estrogen receptor modulator. Int J Clin Pharmacol Ther. 41:331–345. 2003. View Article : Google Scholar : PubMed/NCBI
32	Russell RG, Watts NB, Ebetino FH and Rogers MJ: Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 19:733–759. 2008. View Article : Google Scholar : PubMed/NCBI
33	Riggs BL and Hartmann LC: Selective estrogen-receptor modulators – mechanisms of action and application to clinical practice. N Engl J Med. 348:618–629. 2003.